Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
168 pending office actions • 87 clients • 154 examiners • 75 art units • 0 of 168 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
MEDLER FERRO WOODHOUSE & MILLS PLLC has handled 2584 career applications in the Biotechnology & Pharmaceuticals technology area. The firm maintains a resolved allowance rate of 78.04 percent. Prosecution averages 3.49 office actions per allowance.
The firm is currently managing 141 pending office actions. The 78.04 percent allowance rate across 2584 career applications shows a consistent ability to secure patent rights. The 3.49 average office actions per allowance suggests a standard examination cycle for the biotech sector, while the 141 pending actions indicate a very active current docket for the firm.
Based on the USPTO statutory response window for each pending office action. 57 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 57 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 4 (2%) |
| §101 + other | 18 (11%) |
| §103 only | 36 (21%) |
| §102 only | 3 (2%) |
| §112 only | 15 (9%) |
| Double-patenting only | 5 (3%) |
| Double-patenting + other | 25 (15%) |
| Multi-statute (no §101) | 62 (37%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NATARAJAN, MEERA | 3 | 62.5% | +18.0% |
| TRAN, CHRISTINA L | 3 | 51.6% | +48.2% |
| SAHAND, SANA | 2 | 63.4% | +23.8% |
| PETRASH, HILARY ANN | 2 | 64.5% | +51.7% |
| CROW, ROBERT THOMAS | 2 | 41.7% | +32.7% |
| NERANGIS, VICKEY M | 2 | 56.6% | +29.0% |
| LEE, JIA-HAI | 2 | 49.0% | +47.0% |
| MOSELEY II, NELSON B | 2 | 68.0% | +41.5% |
| ALAM, DANYAL HASSAN | 2 | 66.7% | +0.0% |
| LY, KRISTINA ELISABETH | 2 | 37.5% | +100.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17562316 | METHOD FOR CONTROLLING AN EYE SURGICAL LASER, COMPUTER PROGRAM PRODUCT, AND TREATMENT APPARATUS | CHRISTIANSON, SKYLAR LINDSEY | 282d overdue |
| 18258502 | MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY | VIJAYARAGHAVAN, JAGAMYA NMN | 98d overdue |
| 17290061 | Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies | SITTON, JEHANNE SOUAYA | 88d overdue |
| 18258501 | MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY | HILL, MYRON G | 79d overdue |
| 18005438 | EXQUISITE VEGAN CONVENIENCE FOODS AND PRODUCTION THEREOF | MERCHLINSKY, JOSEPH CULLEN | 56d overdue |
| 18631297 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS FOR AVOIDING AN OPAQUE BUBBLE LAYER | LEVICKY, WILLIAM J | 45d overdue |
| 18005917 | STIMULATION ARRANGEMENTS, VENTILATION ARRANGEMENT, STIMULATION METHODS AND VENTILATION METHOD | REDDY, SUNITA | 43d overdue |
| 17344792 | METHOD FOR ISOLATING POLY(A) NUCLEIC ACIDS | HANEY, AMANDA MARIE | 42d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17635322 | EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6 | TRAN, CHRISTINA L | 7d |
| 18675357 | CELLULOSIC COMPOSITE | NERANGIS, VICKEY M | 33d |
| 18253160 | ADJUVANT CONTAINING ZINC ALUMINUM RISEDRONATE, AND APPLICATION THEREOF | LY, KRISTINA ELISABETH | 40d |
| 18969940 | ANTI-PSMA ANTIBODY CONJUGATES | PETRASH, HILARY ANN | 41d |
| 18675209 | CELLULOSIC COMPOSITE | NERANGIS, VICKEY M | 75d |
| 19120100 | MEDICAL ENDODEVICE | SAHAND, SANA | — |
| 18971848 | ANTI-CLAUDIN-6 CONJUGATES | PETRASH, HILARY ANN | — |
| 18869443 | RESPIRATION PROMOTING APPARATUS | SAHAND, SANA | — |
| Art Unit | Apps |
|---|---|
| 3796 | 7 |
| 1637 | 7 |
| 1654 | 6 |
| 3791 | 5 |
| 1658 | 4 |
| 3792 | 4 |
| 1642 | 4 |
| 1671 | 4 |
| 1638 | 4 |
| 1644 | 3 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19544782 | FORMULATIONS COMPRISING A COMBINATION OF ACID-NEUTRALIZING POLYMERIC AND NON-POLYMERIC SUBSTANCES FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | Entera Bio Ltd. | ALLEY, GENEVIEVE S | 1617 | §103§112DP | Non-Final OA | — | Pending | Feb 19, 2026 |
| 19440230 | FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF PARATHYROID HORMONE | Entera Bio Ltd. | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §103DP | Non-Final OA | — | Pending | Jan 05, 2026 |
| 19433400 | LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND A PROCESS FOR PREPARATION | Pharmazz, Inc. | BERHANE, SELAM | 1675 | §102 | Non-Final OA | — | Pending | Dec 26, 2025 |
| 19489804 | WHEEL SUSPENSION FOR A MOTOR VEHICLE | Muhr Und Bender Kg | TO, TOAN C | 3614 | §112 | Non-Final OA | — | Pending | Dec 03, 2025 |
| 19228139 | RESOURCE-SAVING CLOSURE DEVICE | BERICAP Holding GmbH | SMALLEY, JAMES N | §102§103§112 | Non-Final OA | — | Pending | Jun 04, 2025 | |
| 19223202 | Milking Robot Controller, Method therefore, Computer Program and Non-Volatile Data Carrier | Delaval Holding AB | NGUYEN, ROBERT T | 3642 | §103§112 | Non-Final OA | — | Pending | May 30, 2025 |
| 19123637 | DEHUMIDIFYING SYSTEM | Munters Europe Aktiebolag | VAZQUEZ, ANA M | 3763 | §103 | Non-Final OA | — | Pending | Apr 23, 2025 |
| 19181886 | DEVICE, SYSTEM AND METHOD FOR INSPECTING THREE-DIMENSIONAL OBJECTS | Isra Vision GmbH | KO, TONY | §112 | Non-Final OA | — | Pending | Apr 17, 2025 | |
| 19120100 | MEDICAL ENDODEVICE | UNIVERSITÄT BASEL | SAHAND, SANA | §101§103§112 | Non-Final OA | — | Pending | Apr 10, 2025 | |
| 19076661 | STABLE PHARMACEUTICAL COMPOSITION OF AN AMINE DRUG | Sun Pharmaceutical Industries, Ltd. | TCHERKASSKAYA, OLGA V | 1615 | §103§112 | Non-Final OA | — | Pending | Mar 11, 2025 |
| 19107911 | INSPECTION SYSTEM AND METHOD FOR A CLOSED MEDICAL CONTAINER | Hoffmann-La Roche, Inc. | AKANBI, ISIAKA O | §102 | Non-Final OA | — | Pending | Feb 28, 2025 | |
| 18877641 | METHOD FOR PROCESSING POSE INFORMATION IN AN AT LEAST PARTIALLY AUTOMATED VEHICLE AND/OR ROBOT | Mercedes-Benz Group AG | NGUYEN, CUONG H | 3664 | §103 | Final Rejection | 15d | Pending | Dec 20, 2024 |
| 18985583 | ENDOSCOPE WITH INERTIAL MEASUREMENT UNITS AND/OR HAPTIC INPUT CONTROLS | Elements Endoscopy Inc. | WOO, JAE KYUN | §102§103§112 | Non-Final OA | — | Pending | Dec 18, 2024 | |
| 18971848 | ANTI-CLAUDIN-6 CONJUGATES | Adc Therapeutics SA | PETRASH, HILARY ANN | 1644 | §103DP | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18969940 | ANTI-PSMA ANTIBODY CONJUGATES | Adc Therapeutics SA | PETRASH, HILARY ANN | 1644 | §103Other | Non-Final OA | 41d | Pending | Dec 05, 2024 |
| 18869443 | RESPIRATION PROMOTING APPARATUS | Stimit AG | SAHAND, SANA | §103§112 | Non-Final OA | — | Pending | Nov 26, 2024 | |
| 18957184 | TESTOSTERONE AND ESTRADIOL TRANSDERMAL SPRAY | Celista Pharmaceuticals LLC | SONG, JIANFENG | §103§112DP | Non-Final OA | — | Pending | Nov 22, 2024 | |
| 18946353 | INFORMATION PROCESSING METHOD, NON-TRANSITORY STORAGE MEDIUM, AND INFORMATION PROCESSING APPARATUS | Tsz Tat Chu | MAHROUKA, WASSIM | §101§103§112 | Non-Final OA | — | Pending | Nov 13, 2024 | |
| 18938929 | QUALITY CONTROL METHODS FOR AUTOMATED CELL PROCESSING | Lonza Walkersville, Inc. | WESTON, ALYSSA G | §103§112DP | Non-Final OA | — | Pending | Nov 06, 2024 | |
| 18923071 | COMPACT MIXED ARRAY IMAGING PROBE | Deepsight Technology, Inc. | FARAG, AMAL ALY | 3798 | §102§103§112 | Non-Final OA | — | Pending | Oct 22, 2024 |
| 18889738 | TREATMENT APPARATUS AND METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS FOR THE LASER-INDUCED REFRACTIVE INDEX CHANGE | Schwind Eye-Tech-Solutions GmbH | FAIRCHILD, MALLIKA DIPAYAN | 3792 | §101 | Non-Final OA | — | Pending | Sep 19, 2024 |
| 18841618 | TOPICAL COMPOSITIONS AND USES THEROF | Topadur Pharma AG | SHTERENGARTS, SAMANTHA L | §103§112DP | Non-Final OA | — | Pending | Aug 26, 2024 | |
| 18840561 | SAMPLE PREPARATION FOR GLYCOPROTEOMIC ANALYSIS THAT INCLUDES DIAGNOSIS OF DISEASE | VENN BIOSCIENCES CORPORATION | FRANK, RODNEY T | §103§112 | Non-Final OA | — | Pending | Aug 22, 2024 | |
| 18798864 | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | Entera Bio Ltd. | PALENIK, JEFFREY T | 1615 | §103 | Final Rejection | — | Pending | Aug 09, 2024 |
| 18798508 | GUANINE-RICH OLIGONUCLEOTIDES | Kuros US LLC | CROW, ROBERT THOMAS | §103§112 | Non-Final OA | — | Pending | Aug 08, 2024 | |
| 18835518 | 3-SUBSTITUTED PYRIDAZINE COMPOUNDS AS SMARCA2 AND/OR SMARCA4 DEGRADERS | Aurigene Discovery Technologies Limited | BURKETT, DANIEL JOHN | §102§112 | Non-Final OA | — | Pending | Aug 02, 2024 | |
| 18780030 | METHODS OF CELL SELECTION AND MODIFYING CELL METABOLISM | LONZA LTD | PAK, YONG D | 1652 | §103§112 | Non-Final OA | — | Pending | Jul 22, 2024 |
| 18776688 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS | Schwind Eye-Tech-Solutions GmbH | HOUGH, JESSANDRA F | 3796 | §101§103 | Non-Final OA | 29d | Pending | Jul 18, 2024 |
| 18772698 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS, CONTROL DEVICE THEREFOR, TREATMENT APPARATUS, COMPUTER PROGRAM PRODUCT AND COMPUTER-READABLE MEDIUM | Schwind Eye-Tech-Solutions GmbH | MARSH, OWEN LEWIS | 3796 | §101§102§103§112 | Non-Final OA | 29d | Pending | Jul 15, 2024 |
| 18728675 | FUNCTIONALIZED AMINOTHIAZOLES | Leadxpro AG | REDWOOD, CHRISTOPHER EVAN | §103 | Non-Final OA | — | Pending | Jul 12, 2024 | |
| 18771844 | SECURE RECONSTITUTION DEVICE | Duoject Medical Systems Inc. | DEAK, LESLIE R | DP | Non-Final OA | — | Pending | Jul 12, 2024 | |
| 18766913 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS | Schwind Eye-Tech-Solutions GmbH | HILSMIER, HEIDI ANN | 3796 | §101§102§103 | Non-Final OA | 34d | Pending | Jul 09, 2024 |
| 18760523 | FIBER-OPTICAL SENSOR SYSTEM FOR ULTRASOUND SENSING AND IMAGING | Deepsight Technology, Inc. | PLUMB, NIGEL H | 2855 | DP | Non-Final OA | — | Pending | Jul 01, 2024 |
| 18724799 | SELF-ADMINISTRATION INJECTION DEVICE FOR RISPERIDONE | Orbicular Pharmaceutical Technologies Private Limited | WHITROCK, ZACHARIAH KIRBY | §103§112 | Non-Final OA | — | Pending | Jun 27, 2024 | |
| 18754402 | CELL CULTURE AND TISSUE ENGINEERING SYSTEMS WITH CONTROLLED ENVIRONMENTAL ZONES | Octane Biotech Inc. | HENKEL, DANIELLE B | 1799 | §102§103§112 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18721646 | ARRANGEMENT AND PLATE FOR CONDENSING A GASEOUS LIQUID INTO LIQUID STATE | Aktiebolaget Scarab Development | BUI, ANH HUYNH NGOC | §102§103§112 | Non-Final OA | — | Pending | Jun 18, 2024 | |
| 18721640 | METHOD FOR MANUFACTURING AN ARRANGEMENT FOR CONDENSING A GASEOUS LIQUID INTO LIQUID STATE | Aktiebolaget Scarab Development | GROSS, CARSON | 1746 | §103§112 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18720675 | PROSTATE CANCER CLINICAL STATUS MARKERS | UNIVERSITAET ZUERICH | IVICH, FERNANDO NMN | §101§102§103§112 | Non-Final OA | — | Pending | Jun 17, 2024 | |
| 18680666 | INTRALUMINAL LOCAL DRUG DELIVERY | Isola Therapeutics, Inc. | SCHMIDT, EMILY LOUISE | §102§103§112 | Non-Final OA | — | Pending | May 31, 2024 | |
| 18675357 | CELLULOSIC COMPOSITE | Woodcomposite Sweden AB | NERANGIS, VICKEY M | 1763 | §103Other | Non-Final OA | 33d | Pending | May 28, 2024 |
| 18675209 | CELLULOSIC COMPOSITE | Woodcomposite Sweden AB | NERANGIS, VICKEY M | 1763 | §103 | Non-Final OA | 75d | Pending | May 28, 2024 |
| 18712828 | STABLE INJECTABLE COMPOSITIONS OF GLP-2 PEPTIDE | Orbicular Pharmaceutical Technologies Private Limited | GARYU, LIANKO G | §102§103§112Other | Non-Final OA | — | Pending | May 23, 2024 | |
| 18651998 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHAMOLOGICAL LASER OF A TREAMENT APPARATUS FOR CORRECTING AN ASTIGMATISM | Schwind Eye-Tech-Solutions GmbH | HODGE, LAURA NICOLE | 3792 | §101§102§103§112 | Non-Final OA | 9d | Pending | May 01, 2024 |
| 18705455 | SPRAY-DRIED COMPOSITIONS AND METHODS OF PREPARATION | National University Of Singapore | PEEBLES, KATHERINE | 1617 | §103§112 | Final Rejection | 34d | Pending | Apr 26, 2024 |
| 18705292 | MICROFLUIDIC CELL CULTURING DEVICE | UNIVERSITÄT BERN | BRIDGES, DONAVAN LEE | §102§103§112 | Non-Final OA | — | Pending | Apr 26, 2024 | |
| 18645797 | METHOD FOR PROVIDING CONTROL DATA FOR A LASER OF A PROCESSING APPARATUS, CONTROL DEVICE, COMPUTER PROGRAM AND COMPUTER-READABLE MEDIUM | Schwind Eye-Tech-Solutions GmbH | SANDERS, JOSHUA T | 2119 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18633844 | PD-1/TIGIT BINDING PROTEINS FOR CANCER TREATMENT | MedImmune, LLC | ALLEN, MARIANNE P | §103§112Other | Non-Final OA | — | Pending | Apr 12, 2024 | |
| 18700883 | SLEEP-BASED DETECTION AND INTERVENTION SYSTEM | UNIVERSITÄT BERN | DIETZ, NOE ROBERT | §102§103§112 | Non-Final OA | — | Pending | Apr 12, 2024 | |
| 18632522 | R-FADROZOLE FOR USE IN THE TREATMENT OF ALDOSTONERISM | Damian Pharma AG | ROZOF, TIMOTHY R | 1625 | DP | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18631297 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS FOR AVOIDING AN OPAQUE BUBBLE LAYER | Schwind Eye-Tech-Solutions GmbH | LEVICKY, WILLIAM J | 3796 | §102§103 | Final Rejection | 45d overdue | Pending | Apr 10, 2024 |
| 18699059 | ANTI-CD3 MONOCLONAL ANTIBODIES AND THERAPEUTIC CONSTRUCTS | UNIVERSITY OF OTTAWA | NATARAJAN, MEERA | §112 | Non-Final OA | — | Pending | Apr 05, 2024 | |
| 18695801 | METATARSAL IMPLANT | Episurf Ip-Management AB | WATKINS, MARCIA LYNN | 3774 | §103DP | Final Rejection | — | Pending | Mar 26, 2024 |
| 18604899 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER | Schwind Eye-Tech-Solutions GmbH | LEE, ERICA SHENGKAI | 3796 | §101§102 | Non-Final OA | 61d | Pending | Mar 14, 2024 |
| 18687169 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | Genomatica, Inc. | SAIDHA, TEKCHAND | 1652 | §112 | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18685985 | MULTI-DIMENSIONAL SIGNAL DETECTION WITH OPTICAL SENSORS | Deepsight Technology, Inc. | BRYANT, CHRISTIAN THOMAS | 3619 | §101§102§103 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18444169 | DEVICES AND SYSTEMS FOR INTRALUMINAL LOCAL DRUG DELIVERY | Isola Therapeutics, Inc. | BRANDT, DAVID NELSON | §103§112Other | Non-Final OA | — | Pending | Feb 16, 2024 | |
| 18432185 | TREATMENT OF HYPOPARATHYROIDISM | Entera Bio Ltd. | REYNOLDS, FRED H | 1658 | §103Other | Final Rejection | 30d overdue | Pending | Feb 05, 2024 |
| 18427293 | PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES AND USES THEREOF | MedImmune, LLC | PUTTLITZ, KARL J | 1642 | §112DP | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18292538 | GENERAL AFFINITY EPITOPE POLYPEPTIDE FOR HUMAN RHINOVIRUS, AND ANTIBODY AND USES THEREOF | Xiamen University | WANG, RUIXUE | 1672 | §103§112 | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18292730 | ELECTRONIC CONVERSION KIT FOR A MOTOR VEHICLE IN WHICH AN INTERNAL COMBUSTION ENGINE IS EXCHANGED FOR AN ELECTRIC TRACTION DRIVE HAVING AN ELECTRIC MOTOR, MOTOR VEHICLE HAVING THE CONVERSION KIT AND OPERATING METHOD FOR THE CONVERSION KIT | E-R3Volt GmbH | WANG, HARRY Z | 2184 | §103 | Non-Final OA | 15d overdue | Pending | Jan 26, 2024 |
| 18291725 | TEAR-OPEN STRIP FOR A PACKAGING AND METHOD FOR PRODUCING A TEAR-OPEN STRIP | Mayr-Melnhof Karton AG | ZHANG, MICHAEL N | 1781 | §103 | Non-Final OA | 32d overdue | Pending | Jan 24, 2024 |
| 18291326 | HANDHELD GYNECOLOGICAL DEVICE, HANDLE AND ROD MEMBER | Aspivix SA | LONG, SARAH A | 3771 | §103 | Final Rejection | — | Pending | Jan 23, 2024 |
| 18577945 | PHARMACEUTICAL COMPOSITIONS OF A B7-H3 ANTIBODY AND USE OF THE SAME | Macrogenics, Inc. | NATARAJAN, MEERA | §102§112 | Non-Final OA | — | Pending | Jan 09, 2024 | |
| 18403384 | SHARED ELECTRIC BIKE WITH INTEGRATED FRAME AND LAMPS | VEORIDE INC. | LEE, MATTHEW D | 3617 | §102§103 | Final Rejection | 11d overdue | Pending | Jan 03, 2024 |
| 18394869 | HER2/neu-Specific Antibodies and Methods of Using Same | Tersera Therapeutics LLC | NATARAJAN, MEERA | §103DP | Non-Final OA | — | Pending | Dec 22, 2023 | |
| 18572508 | COMPOSITION FOR DETECTING MICROBIAL ON-SITE CONTAMINATION AND USE THEREOF | BIONANO HEALTH GUARD RESEARCH CENTER | GOLDBERG, JEANINE ANNE | 1682 | §102§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18572300 | COMBINATION THERAPY USING ANTIBODY-DRUG CONJUGATES | MedImmune, LLC | PETERS, ALEC JON | §103§112DP | Non-Final OA | — | Pending | Dec 20, 2023 | |
| 18545392 | NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS | UNIVERSITÄT BERN | LEE, JIA-HAI | 1658 | §102§103§112DP | Final Rejection | — | Pending | Dec 19, 2023 |
| 18571164 | PRPF31 VARIANT AND USES THEREOF | Chigenovo Co., Ltd. | YU, DAVID TUYANG | §103§112 | Non-Final OA | — | Pending | Dec 15, 2023 | |
| 18539883 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER FOR PROVIDING A TRANSITION ZONE BETWEEN INTERFACES | Schwind Eye-Tech-Solutions GmbH | MALAMUD, DEBORAH LESLIE | 3792 | §101§102 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18533836 | METHOD FOR ISOLATING NUCLEIC ACIDS FROM A FORMALDEHYDE RELEASER STABILIZED SAMPLE | Qiagen GmbH | CROW, ROBERT THOMAS | §103 | Final Rejection | — | Pending | Dec 08, 2023 | |
| 18557748 | APPLICATION OF ARTIFICIALLY SYNTHESIZED CPG SINGLE-STRANDED DEOXYOLIGONUCLEOTIDE IN VACCINES | Parr Biotechnology (Hebei) Co., Ltd. | ZOU, NIANXIANG | 1671 | §102§103§112DP | Final Rejection | — | Pending | Dec 01, 2023 |
| 18561525 | REDOX SENSITIVE CRALBP MUTANT PROTEINS | UNIVERSITÄT BERN | BREEN, KIMBERLY CATHERINE | 1657 | §112 | Final Rejection | — | Pending | Nov 16, 2023 |
| 18502863 | TOPICAL OXYBUTYNIN FOR HOT FLASHES | Celista Pharmaceuticals LLC | BRAM, STANLEY | 1691 | §102§103§112 | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18499658 | METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH PD-1 AND CTLA-4 | Macrogenics, Inc. | MOSELEY II, NELSON B | 1642 | §112DP | Non-Final OA | — | Pending | Nov 01, 2023 |
| 18557414 | TRANSGENIC RODENTS EXPRESSING CHIMERIC EQUINE-RODENT ANTIBODIES AND METHODS OF USE THEREOF | Trianni, Inc. | SINGH, ANOOP KUMAR | 1632 | §102§112 | Non-Final OA | 84d | Pending | Oct 26, 2023 |
| 18556287 | FUNCTIONALIZED BIOCATALYTICAL COMPOSITIONS | Perseo Pharma AG | SHOMER, ISAAC | 1612 | §103DP | Non-Final OA | 10d overdue | Pending | Oct 19, 2023 |
| 18484921 | MULTl-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS | Macrogenics, Inc. | BRISTOL, LYNN ANNE | 1643 | §103§112Other | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18286301 | LAYER COMPOSITE FOR USE AS AN IMITATION LEATHER | Nuvi Releaf GmbH | SALVATORE, LYNDA | 1789 | §103 | Non-Final OA | — | Pending | Oct 10, 2023 |
| 18480841 | METHODS FOR CHARACTERIZING LENTIVIRUSES | Lonza Houston, Inc. | ALAM, DANYAL HASSAN | 1672 | §103§112 | Final Rejection | 23d overdue | Pending | Oct 04, 2023 |
| 18478528 | LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND METHOD FOR PREPARATION THEREOF | Pharmazz, Inc. | D' AMBROSIO, THEA | 1654 | §103§112Other | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18553010 | CONTROL OF AN ENERGY STORAGE ARRANGEMENT | Martin Huber | MURALIDAR, RICHARD V | §102§103 | Non-Final OA | — | Pending | Sep 28, 2023 | |
| 18373470 | EDGE PROTECTION MOUNTING DEVICE IN A SYSTEM FOR SHEET COIL PACKAGING | Lamiflex Group AB | HIBBERT, MARY C | 3731 | §101§112DP | Non-Final OA | — | Pending | Sep 27, 2023 |
| 18552468 | VARIANTS OF RHIZOMUCOR MIEHEI LIPASE AND USES THEREOF | Wilmar International Limited | KANE, TREVOR LOGAN | 1657 | §102§103§112 | Final Rejection | 9d overdue | Pending | Sep 26, 2023 |
| 18552338 | MODIFIED CHIMERIC CORONAVIRUS SPIKE PROTEIN FOR ENHANCEMENT OF VIRAL TITERS | Iosbio Ltd. | LY, KRISTINA ELISABETH | 1671 | §102§103§112 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18462800 | METHOD FOR PRODUCING BIOLOGIC PRODUCT VARIANTS | LONZA LTD | MIANO, JOSEPH PAUL | 1631 | §101§102§103 | Non-Final OA | — | Pending | Sep 07, 2023 |
| 18237675 | 4-THIOCARBAMOYLPHENYL 2-(4-OXOPHENYL)-PHENYL PROPANOATE FOR THE TREATMENT OF PAIN ASSOCIATED WITH UROLOGIC CHRONIC PELVIC PAIN SYNDROME | Antibe Therapeutics Inc. | HIRAKIS, SOPHIA P | 1623 | §102§112DP | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18454930 | CARBON-SOURCE REGULATED PROTEIN PRODUCTION IN A RECOMBINANT HOST CELL | LONZA LTD | MEAH, MOHAMMAD Y | 1652 | §103§112DP | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18277161 | METHOD AND A SENSOR FOR DETERMINING A CONCENTRATION OF A TARGET GAS IN THE BLOOD OF AN ANIMATE BEING | Albert-Ludwigs-Universität Freiburg | MCCORMACK, ERIN KATHLEEN | 3791 | §103§112 | Non-Final OA | — | Pending | Aug 14, 2023 |
| 18546131 | EXTRACELLULAR VESICLE LINKED TO A BIOLOGICALLY ACTIVE MOLECULE VIA AN OPTIMIZED LINKER AND AN ANCHORING MOIETY | Lonza Sales AG | LEWOCZKO, EVAN MICHAEL | 1612 | §103DP | Non-Final OA | — | Pending | Aug 11, 2023 |
| 18264332 | TREATMENT OF SKIN DISORDERS | BACOBA AG | BANERJEE, KOYELI | 1654 | §103§112 | Non-Final OA | — | Pending | Aug 04, 2023 |
| 17906177 | EXTRACELLULAR VESICLES FOR TREATING NEUROLOGICAL DISORDERS | Lonza Sales AG | LEE, JIA-HAI | 1658 | §101§102§103DP | Non-Final OA | — | Pending | Aug 01, 2023 |
| 18354770 | CELL CULTURE CHAMBER FOR INCREASED CELL YIELD | Octane Biotech Inc. | MUTREJA, JYOTI NAGPAUL | 1798 | §102§103 | Non-Final OA | — | Pending | Jul 19, 2023 |
| 18272961 | SET OF CHEMICALS FOR THE PREPARATION OF A POLYMER | Chemische Fabrik Budenheim Kg | JOHNSTON, BRIEANN R | 1766 | §102§103§112 | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18261934 | PROCESS FOR PREPARING METAL OXIDE NANOSHEETS | Royal Melbourne Institute Of Technology | NGUYEN, CAM N | 1736 | §103 | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18258684 | CHARGING DEVICE AND METHOD FOR CHARGING AN ELECTRICAL STORED ENERGY SOURCE OF AN ELECTRICALLY OPERABLE VEHICLE | Brusa Technology AG | KIK, PHALLAKA | 2851 | §102 | Non-Final OA | — | Pending | Jun 21, 2023 |
| 18268933 | Composition Comprising Calcium Orthophosphate and a Bioactive Glass Comprising Fluorine | Queen Mary University Of London | LIU, TRACY | 1614 | §103 | Final Rejection | 38d overdue | Pending | Jun 21, 2023 |
| 18258501 | MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY | Prime Vector Technologies Gmby | HILL, MYRON G | 1671 | §102§103§112 | Final Rejection | 79d overdue | Pending | Jun 20, 2023 |
| 18258502 | MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY | Prime Vector Technologies GmbH | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §101§102§103§112 | Final Rejection | 98d overdue | Pending | Jun 20, 2023 |
| 18257749 | ANTI-BCMA ANTIBODY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Wuhan Yzy Biopharma Co., Ltd. | SAOUD, CHRISTINE J | 1645 | §112 | Non-Final OA | — | Pending | Jun 15, 2023 |
| 18331573 | MATERIAL PROCESSING APPARATUS AND METHOD FOR PREPARING A MATERIAL PROCESSING APPARATUS | Schwind Eye-Tech-Solutions GmbH | WIBLIN, MATTHEW | 3745 | §102§112 | Non-Final OA | — | Pending | Jun 08, 2023 |
| 18255525 | HEAVY CHAIN-ONLY ANTIBODIES | Trianni, Inc. | WILSON, MICHAEL C | 1638 | §112 | Final Rejection | 2d overdue | Pending | Jun 01, 2023 |
| 18253853 | NUCLEIC ACID DUPLEXES | Alpha Anomeric SAS | GROOMS, TIFFANY NICOLE | 1637 | §112 | Non-Final OA | — | Pending | May 22, 2023 |
| 18321354 | Variant CD3-Binding Domains and Their Use in Combination Therapies for the Treatment of Disease | Macrogenics, Inc. | MOSELEY II, NELSON B | 1642 | DP | Non-Final OA | — | Pending | May 22, 2023 |
| 18197975 | FIRE EXTINGUISHER, A SYSTEM FOR MONITORING A FIRE EXTINGUISHER, AND METHODS FOR DETECTING LEAKAGE FROM A FIRE EXTINGUISHER | Cosesy A/S | LIEUWEN, CODY J | 3752 | §103 | Non-Final OA | 8d | Pending | May 16, 2023 |
| 18253160 | ADJUVANT CONTAINING ZINC ALUMINUM RISEDRONATE, AND APPLICATION THEREOF | Xiamen Innovax Biotech Co., Ltd. | LY, KRISTINA ELISABETH | 1671 | §102§103Other | Final Rejection | 40d | Pending | May 16, 2023 |
| 18316828 | CASTRATION RESISTANT PROSTATE CANCER | Targimmune Therapeutics AG | LIPPOLIS, ALEXANDRA ROSE | 1637 | §101§103§112 | Final Rejection | 31d overdue | Pending | May 12, 2023 |
| 18251450 | ENDODEVICE | UNIVERSITÄT BASEL | WALKER, OLIVIA | 3796 | §102§103 | Non-Final OA | — | Pending | May 02, 2023 |
| 18251006 | USE OF ANTI-TREM1 NEUTRALIZING ANTIBODIES FOR THE TREATMENT OF MOTOR NEURON NEURODEGENERATIVE DISORDERS | UCB Biopharma SRL | HUYNH, PHUONG N | 1641 | §102§103§112Other | Final Rejection | — | Pending | Apr 28, 2023 |
| 18300994 | METHODS FOR NUCLEAR REPROGRAMMING USING SYNTHETIC TRANSCRIPTION FACTORS | Lonza Walkersville, Inc. | MCCORMICK, CATHERINE LYNN | 1638 | §103Other | Non-Final OA | — | Pending | Apr 14, 2023 |
| 18248651 | BINDING MOLECULES THAT MULTIMERISE CD45 | UCB Biopharma SRL | OUSPENSKI, ILIA I | 1644 | §102§103§112 | Non-Final OA | 33d | Pending | Apr 11, 2023 |
| 18246403 | STIMULATION DEVICE AND METHOD OF STIMULATING A NERVE | Stimit AG | LANDEEN, BROGAN RANE | 3791 | §102§103§112 | Non-Final OA | 11d overdue | Pending | Mar 23, 2023 |
| 18246301 | PROCESS FOR PREPARING EXTRACELLULAR VESICLES | Lonza Sales AG | BREWSTER, HAYDEN R | 1779 | §103 | Final Rejection | 44d overdue | Pending | Mar 22, 2023 |
| 18246312 | PROCESS FOR PREPARING EXTRACELLULAR VESICLES | Lonza Sales AG | ROYCE, LIAM A | 1777 | §103 | Final Rejection | 7d | Pending | Mar 22, 2023 |
| 18245739 | SHAVING COMPOSITION | Fallien Cosmeceuticals, Ltd. | PRAGANI, RAJAN | 1614 | §102§103§112 | Final Rejection | — | Pending | Mar 17, 2023 |
| 18180789 | IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND TREATMENT MONITORING | VENN BIOSCIENCES CORPORATION | XU, XIAOYUN | 1797 | §102§103Other | Final Rejection | 28d | Pending | Mar 08, 2023 |
| 18024927 | COMPOSITION CONTAINING AMMONIUM POLYPHOSHATE | Chemische Fabrik Budenheim Kg | USELDING, JOHN E | 1763 | §103 | Non-Final OA | — | Pending | Mar 06, 2023 |
| 18169936 | IDENTIFICATION, CONFIGURATION AND CONTROL OF AN ELECTRIC APPLIANCE | Einhell Germany AG | FUREMAN, JARED | 2859 | DP | Final Rejection | — | Pending | Feb 16, 2023 |
| 18164952 | Covalent Diabodies and Uses Thereof | Macrogenics, Inc. | DUFFY, BRADLEY | 1643 | §103 | Final Rejection | 23d | Pending | Feb 06, 2023 |
| 18158767 | METHODS FOR TREATMENT OF SUBJECTS WITH PLAQUE PSORIASIS OF THE SCALP | Sun Pharmaceutical Industries, Ltd. | DONOGHUE, BRITTNEY ERIN | 1675 | §103 | Final Rejection | 88d overdue | Pending | Jan 24, 2023 |
| 18006294 | METHODS FOR THE USE OF A PD-1 X CTLA-4 BISPECIFIC MOLECULE | Macrogenics, Inc. | YU, MISOOK | 1641 | §102§103§112DPOther | Non-Final OA | — | Pending | Jan 20, 2023 |
| 18098985 | CREATION OF A HEALTHIER PATELLOFEMORAL JOINT | Episurf Ip-Management AB | LIN, JESSICA YIFANG | 1687 | §103 | Final Rejection | — | Pending | Jan 19, 2023 |
| 18005917 | STIMULATION ARRANGEMENTS, VENTILATION ARRANGEMENT, STIMULATION METHODS AND VENTILATION METHOD | Stimit AG | REDDY, SUNITA | 3791 | §103§112 | Non-Final OA | 43d overdue | Pending | Jan 18, 2023 |
| 17999288 | SERUM-FREE INDUCTION METHOD FOR SENSORY NEURON CELL | Iregene Therapeutics Ltd. | ROGERS, ERIC JASON | 1638 | §112 | Final Rejection | 14d | Pending | Jan 18, 2023 |
| 18005543 | CELL-PENETRATING PEPTIDE AND USE THEREOF | Xiamen University | JAUHARI, SACHI | 1654 | §101§112 | Final Rejection | — | Pending | Jan 13, 2023 |
| 18005401 | PHARMACEUTICAL COMPOSITIONS | Extrovis AG | HA, JULIE | 1654 | §102§103 | Non-Final OA | — | Pending | Jan 13, 2023 |
| 18005438 | EXQUISITE VEGAN CONVENIENCE FOODS AND PRODUCTION THEREOF | Othmar Kaeppeli | MERCHLINSKY, JOSEPH CULLEN | 1791 | §102§103 | Final Rejection | 56d overdue | Pending | Jan 13, 2023 |
| 18003872 | CONSTRUCTION AND APPLICATION OF FUSION PROTEIN VACCINE PLATFORM | Institute Of Biophysics, Chinese Academy Of Sciences | SKOKO III, JOHN JOSEPH | 1643 | §103§112DP | Final Rejection | — | Pending | Dec 29, 2022 |
| 18063982 | METHODS FOR PRODUCING IMMUNE CELL CULTURES | Lonza Walkersville, Inc. | VANHORN, ABIGAIL LOUISE | 1636 | §103 | Non-Final OA | — | Pending | Dec 09, 2022 |
| 18001025 | Use of Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies | Nottingham Trent University | GODDARD, LAURA B | 1642 | §112 | Final Rejection | 22d overdue | Pending | Dec 07, 2022 |
| 18000546 | METHOD OF MAKING VIRUS-LIKE PARTICLE | Icosavax, Inc. | ANTHOPOLOS, PETER | 1611 | §103§112 | Non-Final OA | 26d | Pending | Dec 02, 2022 |
| 18057709 | COMPOSITIONS OF ENGINEERED EXOSOMES AND METHODS OF LOADING LUMINAL EXOSOMES PAY-LOADS | Lonza Sales AG | CARTER, SANDRA DILLAHUNT | 1674 | §112 | Non-Final OA | — | Pending | Nov 21, 2022 |
| 17997804 | REGENTIDE-034 AND COMPOSITION FOR IMPROVING CONDITION OF SKIN, CONTAINING SAME | Ninebiopharm Co., Ltd. | AUDET, MAURY A | 1654 | §101 | Final Rejection | — | Pending | Nov 02, 2022 |
| 17921915 | APPARATUS FOR THE AUTOMATED DIAGNOSTIC ANALYSIS OF LIQUID SAMPLES | Diasys Technologies S.A.R.L. | HERBERT, MADISON TAYLOR | 1758 | §103 | Final Rejection | — | Pending | Oct 27, 2022 |
| 17997266 | METHODS AND KITS FOR DETECTING ADENO-ASSOCIATED VIRUSES | Lonza Houston, Inc. | ALAM, DANYAL HASSAN | 1672 | §103§112 | Non-Final OA | — | Pending | Oct 27, 2022 |
| 18050017 | EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6 | Lonza Sales AG | TRAN, CHRISTINA L | 1637 | §103DP | Non-Final OA | — | Pending | Oct 26, 2022 |
| 17917410 | STIMULATION ARRANGEMENT AND METHOD OF OPERATING SUCH STIMULATION ARRANGEMENT | Stimit AG | MATTHEWS, CHRISTINE HOPKINS | 3791 | §102§112 | Final Rejection | 9d | Pending | Oct 06, 2022 |
| 17936020 | METHODS FOR PROCESSING AND ANALYZING EXTRACELLULAR VESICLES | Exosomics Spa | MARCSISIN, ELLEN JEAN | 1677 | §103Other | Non-Final OA | 1d overdue | Pending | Sep 28, 2022 |
| 17936027 | METHODS FOR PROCESSING AND ANALYZING CELL-DERIVED VESICLES | Mdimune Inc. | MARTIN, PAUL C | 1653 | §103 | Non-Final OA | — | Pending | Sep 28, 2022 |
| 17952439 | STANDARDIZED IMPLANT WITH INDIVIDUALIZED GUIDE TOOL | Episurf Ip-Management AB | BATES, DAVID W | 3799 | §103 | Final Rejection | 34d | Pending | Sep 26, 2022 |
| 17907116 | AUTONOMOUS KNOB DOMAIN PEPTIDES | UCB Biopharma SRL | ALFANO, ALAN | 1641 | §112 | Final Rejection | 4d overdue | Pending | Sep 23, 2022 |
| 17904346 | PRO-MACROBODIES FOR THE ENHANCEMENT OF STRUCTURE RESEARCH | Leadxpro AG | DEBERRY, REGINA M | 1647 | §112 | Final Rejection | — | Pending | Aug 16, 2022 |
| 17760241 | RECOVERY OF VANADIUM FROM ALKALINE SLAG MATERIALS | Avanti Materials Ltd. | PULLEN, NIKOLAS TAKUYA | 1733 | §103 | Final Rejection | 28d | Pending | Aug 05, 2022 |
| 17757345 | AUTOMATED PRODUCTION OF VIRAL VECTORS | Lonza Sales AG | MCCORMICK, CATHERINE LYNN | 1638 | §103 | Final Rejection | — | Pending | Jun 14, 2022 |
| 17751984 | END-TO-END CELL THERAPY AUTOMATION | Octane Biotech Inc. | HASSAN, LIBAN M | 1636 | §101§102§103§112 | Non-Final OA | — | Pending | May 24, 2022 |
| 17776932 | METHODS OF CELL SELECTION | LONZA LTD | LEVIN, JOEL D | 1633 | §103 | Final Rejection | 29d | Pending | May 13, 2022 |
| 17735555 | COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS | LONZA LTD | COUNTS, GARY W | 1678 | §103 | Final Rejection | — | Pending | May 03, 2022 |
| 17769118 | RESPIRATION PROMOTING APPARATUS AND USE THEREOF | Stimit AG | KOHUTKA, BROOKE NICOLE | 3791 | §103 | Final Rejection | — | Pending | Apr 14, 2022 |
| 17635638 | PROCESS CONTROL SYSTEMS FOR AUTOMATED CELL ENGINEERING SYSTEMS | Octane Biotech Inc. | SINES, BRIAN J | 1796 | §102§103 | Final Rejection | 10d overdue | Pending | Feb 15, 2022 |
| 17635322 | EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6 | Lonza Sales AG | TRAN, CHRISTINA L | 1637 | §103§112DP | Final Rejection | 7d | Pending | Feb 14, 2022 |
| 17635315 | EXTRACELLULAR VESICLES WITH STAT3-ANTISENSE OLIGONUCLEOTIDES | Lonza Sales AG | TRAN, CHRISTINA L | 1637 | §103 | Final Rejection | — | Pending | Feb 14, 2022 |
| 17635298 | EXTRACELLULAR VESICLES WITH ANTISENSE OLIGONUCLEOTIDES TARGETING KRAS | Lonza Sales AG | ALLEN, SARAH ELIZABETH | 1637 | §102§103§112 | Non-Final OA | 47d | Pending | Feb 14, 2022 |
| 17634897 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | Lonza Sales AG | MEJIAS, SAMANTHA LEE | 1618 | §103DP | Final Rejection | 3d overdue | Pending | Feb 11, 2022 |
| 17666215 | IDENTIFICATION OF DRUGS TARGETING NON-GENETIC DRUG TOLERANCE PROGRAMS IN CANCER | ETH ZÜRICH | HOPPE, EMMA RUTH | 1683 | §101 | Final Rejection | 14d | Pending | Feb 07, 2022 |
| 17626351 | COMPLEX FOR INTRACELLULAR DELIVERY OF MOLECULES | Xiamen Innovax Biotech Co., Ltd. | JONES, DAMERON LEVEST | 1618 | §112Other | Non-Final OA | — | Pending | Jan 11, 2022 |
| 17562316 | METHOD FOR CONTROLLING AN EYE SURGICAL LASER, COMPUTER PROGRAM PRODUCT, AND TREATMENT APPARATUS | Schwind Eye-Tech-Solutions GmbH | CHRISTIANSON, SKYLAR LINDSEY | 3792 | §102§112 | Non-Final OA | 282d overdue | Pending | Dec 27, 2021 |
| 17620615 | METHOD FOR SEPARATING NUCLEIC ACID MOLECULES BY SIZE | Qiagen GmbH | LAFAVE, ELIZABETH ROSE | 1684 | §102§103Other | Final Rejection | — | Pending | Dec 17, 2021 |
| 17603921 | Methods for Treatment of Subjects with Psoriatic Arthritis | Sun Pharmaceutical Industries, Ltd. | FORD, VANESSA L | 1674 | §112 | Non-Final OA | — | Pending | Oct 14, 2021 |
| 17594054 | IMMUNOTHERAPY FOR THE TREATMENT OF CANCER | Targimmune Therapeutics AG | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103§112DP | Non-Final OA | — | Pending | Sep 30, 2021 |
| 17441162 | EXTRACELLULAR VESICLE CONJUGATES AND USES THEREOF | Lonza Sales AG | ANTHOPOLOS, PETER | 1611 | §103§112DP | Non-Final OA | 17d overdue | Pending | Sep 20, 2021 |
| 17426832 | ABUTMENT ARRANGEMENT AND DENTAL RESTORATION KIT | Institut Straumann AG | RUIZ MARTIN, LUIS MIGUEL | 3772 | §103 | Final Rejection | 9d overdue | Pending | Jul 29, 2021 |
| 17344792 | METHOD FOR ISOLATING POLY(A) NUCLEIC ACIDS | Qiagen GmbH | HANEY, AMANDA MARIE | 1682 | §103§112 | Non-Final OA | 42d overdue | Pending | Jun 10, 2021 |
| 17338408 | ENHANCED PRODUCTION OF IMMUNOGLOBULINS | Trianni, Inc. | NICOL, ALEXANDER W | 1634 | §103§112 | Non-Final OA | 61d | Pending | Jun 03, 2021 |
| 17293833 | ENGINEERED EXTRACELLULAR VESICLES AND USES THEREOF | Lonza Sales AG | ESPINOSA, CLAUDIA EDILMA | 1654 | §103§112DP | Final Rejection | 13d | Pending | May 13, 2021 |
| 17290061 | Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies | Nottingham Trent University | SITTON, JEHANNE SOUAYA | 1682 | §101 | Final Rejection | 88d overdue | Pending | Apr 29, 2021 |
| 17136165 | CLEAR LACROSSE HEAD | East Coast Dyes, Inc. | KLAYMAN, AMIR ARIE | 3711 | §103§112 | Final Rejection | — | Pending | Dec 29, 2020 |
| 17112319 | METHOD FOR DETERMINING A CURRENT POSITION OF A PATIENT INTERFACE OF AN EYE SURGICAL LASER BASED ON A PURKINJE IMAGE | Schwind Eye-Tech-Solutions GmbH | ANJARIA, SHREYA PARAG | 3796 | §103 | Non-Final OA | 44d overdue | Pending | Dec 04, 2020 |
| 15125863 | STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | Qiagen GmbH | POPA, ILEANA | 1633 | §103§112 | Non-Final OA | — | Pending | Sep 13, 2016 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial